Hanwha Q CELLS Co., Ltd.
HQCL
HQCL was delisted on the 16th of January, 2019.
0 hedge funds and large institutions have $0 invested in Hanwha Q CELLS Co., Ltd. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 18 closing their positions.
100% less funds holding
Funds holding: 18 → 0 (-18)
100% less capital invested
Capital invested by funds: $2.77M → $0 (-$2.77M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 18
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$1.38M |
| 2 |
KAM
Kassirer Asset Management
Toronto,
Ontario, Canada
|
-$776K |
| 3 |
Millennium Management
New York
|
-$245K |
| 4 |
JP Morgan Chase
New York
|
-$204K |
| 5 |
CMG
Cavalry Management Group
San Francisco,
California
|
-$102K |
HQCL Hedge Fund Activity: Q1 2019 in Review
0 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Hanwha Q CELLS Co., Ltd. (HQCL) for Q1 2019, worth a combined $0 — down 100% from $2.77M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of HQCL and 0 opened new positions — a net loss of 18 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Myriad Asset Management, exiting entirely with an estimated $1.38M sold.
- 0 institutional investors held Hanwha Q CELLS Co., Ltd. (HQCL) as of Q1 2019, down from 18 in Q4 2018.
- Funds reported $0 of Hanwha Q CELLS Co., Ltd. stock for Q1 2019, down 100% quarter-over-quarter.
- 0 funds opened new Hanwha Q CELLS Co., Ltd. positions in Q1 2019 and 18 closed out, a net change of -18 holders.
- The largest Hanwha Q CELLS Co., Ltd. seller in Q1 2019 was Myriad Asset Management, an estimated $1.38M sold.
Based on aggregated 13F filings for Q1 2019.